Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03214120 · ClinicalTrials.gov registry record
Does Modified Ultrafiltration Affect Thromboelastography Results?
A clinical trial of Congenital Heart Disease, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT03214120: Completed study of Congenital Heart Disease, sponsored by Wake Forest University Health Sciences.
NCT03214120 is a study of Congenital Heart Disease that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 40 participants, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03214120, a study of Congenital Heart Disease, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is to evaluate the effect of modified ultrafiltration on different components of Thromboelastography (TEG) in neonates undergoing cardiac surgery using cardiopulmonary bypass.
Primary Outcome
effect of modified ultrafiltration on different components of thromboelastography
Conditions Studied
Study Locations (1)
Illinois
- Advocate Children's Hospital - Oak Lawn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-01-08 |
| Est. Completion | 2019-01-01 |
What the finished NCT03214120 record still lists
NCT03214120 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Congenital Heart Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03214120 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03214120 about?
NCT03214120 is a clinical study titled "Does Modified Ultrafiltration Affect Thromboelastography Results?". The study is to evaluate the effect of modified ultrafiltration on different components of Thromboelastography (TEG) in neonates undergoing cardiac surgery using cardiopulmonary bypass.
What is the current status of trial NCT03214120?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2018-01-08. Estimated completion is 2019-01-01.
What conditions does trial NCT03214120 study?
This clinical trial studies the following conditions: Congenital Heart Disease.
Who is sponsoring clinical trial NCT03214120?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03214120 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03214120's enrollment target sits among peer trials
40 49th of 63 higher than 13 of 63 other Congenital Heart Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congenital Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fontan Fitness Trial
RECRUITING · NA
-
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
RECRUITING
-
A Study of Invasive Hemodynamic for MACHD Registry
RECRUITING
-
Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables
RECRUITING
-
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
RECRUITING
-
PDA for Kidneys Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI